Cerebral and blood correlates of reduced functional connectivity in mild cognitive impairment

Brain Structure and Function

Volumn 221, Issue 1, 2016, Pages 631-645

  Gonzalez Escamilla, Gabriel ^a   Atienza, Mercedes ^a   Garcia Solis, David ^b   Cantero, Jose L ^a  

^a UNIVERSIDAD PABLO DE OLAVIDE   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Alpha rhythm; Cholesterol; FDG PET; Functional connectivity; Grey matter; Lipid markers; Mild cognitive impairment; Plasma amyloid beta; Resting state cortical networks

Indexed keywords

AMYLOID BETA PROTEIN; APOB PROTEIN, HUMAN; APOLIPOPROTEIN B100; APOLIPOPROTEIN E4; BIOLOGICAL MARKER; FLUORODEOXYGLUCOSE F 18; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; RADIOPHARMACEUTICAL AGENT; TRIACYLGLYCEROL;

AGE; AGED; ALPHA RHYTHM; BLOOD; BRAIN CORTEX; BRAIN MAPPING; CASE CONTROL STUDY; COGNITION; COGNITIVE DEFECT; DIAGNOSTIC IMAGING; ELECTROENCEPHALOGRAPHY; FEMALE; GENETICS; GRAY MATTER; HUMAN; MALE; METABOLISM; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; PSYCHOLOGY;

AGE FACTORS; AGED; ALPHA RHYTHM; AMYLOID BETA-PEPTIDES; APOLIPOPROTEIN B-100; APOLIPOPROTEIN E4; BIOMARKERS; BRAIN MAPPING; CASE-CONTROL STUDIES; CEREBRAL CORTEX; CHOLESTEROL, HDL; COGNITION; COGNITIVE DYSFUNCTION; ELECTROENCEPHALOGRAPHY; FEMALE; FLUORODEOXYGLUCOSE F18; GRAY MATTER; HUMANS; LIPIDS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TRIGLYCERIDES;

EID: 84955355838     PISSN: 18632653     EISSN: 18632661     Source Type: Journal    
DOI: 10.1007/s00429-014-0930-6     Document Type: Article

References (114)

1. Amariglio RE, Becker JA, Carmasin J, Wadsworth LP, Lorius N, Sullivan C, Maye JE, Gidicsin C, Pepin LC, Sperling RA, Johnson KA, Rentz DM (2012) Subjective cognitive complaints and amyloid burden in cognitively normal older individuals. Neuropsychologia 50:2880–2886
2. Ancelin ML, Carrière I, Barberger-Gateau P, Auriacombe S, Rouaud O, Fourlanos S, Berr C, Dupuy AM, Ritchie K (2012) Lipid lowering agents, cognitive decline, and dementia: the three-city study. J Alzheimers Dis 30:629–637
3. Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoesen GW (1991) The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer’s disease. Cereb Cortex 1:103–116
4. Ashburner J (2007) A fast diffeomorphic image registration algorithm. Neuroimage 38:95–113
5. Ashburner J, Friston KJ (2000) Voxel-based morphometry—the methods. Neuroimage 11:805–821
6. Babiloni C, Ferri R, Moretti DV, Strambi A, Binetti G, Dal Forno G, Ferreri F, Lanuzza B, Bonato C, Nobili F, Rodriguez G, Salinari S, Passero S, Rocchi R, Stam CJ, Rossini PM (2004) Abnormal fronto-parietal coupling of brain rhythms in mild Alzheimer’s disease: a multicentric EEG study. Eur J Neurosci 19:2583–2590
7. Babiloni C, Ferri R, Binetti G, Cassarino A, Dal Forno G, Ercolani M, Ferreri F, Frisoni GB, Lanuzza B, Miniussi C, Nobili F, Rodriguez G, Rundo F, Stam CJ, Musha T, Vecchio F, Rossini PM (2006a) Fronto-parietal coupling of brain rhythms in mild cognitive impairment: a multicentric EEG study. Brain Res Bull 69:63–73
8. Babiloni C, Frisoni G, Steriade M, Bresciani L, Binetti G, Del Percio C, Geroldi C, Miniussi C, Nobili F, Rodriguez G, Zappasodi F, Carfagna T, Rossini PM (2006b) Frontal white matter volume and delta EEG sources negatively correlate in awake subjects with mild cognitive impairment and Alzheimer’s disease. Clin Neurophysiol 117:1113–1129
9. Babiloni C, Frisoni GB, Vecchio F, Lizio R, Pievani M, Cristina G, Fracassi C, Vernieri F, Rodriguez G, Nobili F, Ferri R, Rossini PM (2011) Stability of clinical condition in mild cognitive impairment is related to cortical sources of alpha rhythms: an electroencephalographic study. Hum Brain Mapp 32:1916–1931
10. Babiloni C, Carducci F, Lizio R, Vecchio F, Baglieri A, Bernardini S, Cavedo E, Bozzao A, Buttinelli C, Esposito F, Giubilei F, Guizzaro A, Marino S, Montella P, Quattrocchi CC, Redolfi A, Soricelli A, Tedeschi G, Ferri R, Rossi-Fedele G, Ursini F, Scrascia F, Vernieri F, Pedersen TJ, Hardemark HG, Rossini PM, Frisoni GB (2013) Resting state cortical electroencephalographic rhythms are related to gray matter volume in subjects with mild cognitive impairment and Alzheimer’s disease. Hum Brain Mapp 34:1427–1446
11. Babiloni C, Del Percio C, Lizio R, Marzano N, Infarinato F, Soricelli A, Salvatore E, Ferri R, Bonforte C, Tedeschi G, Montella P, Baglieri A, Rodriguez G, Famà F, Nobili F, Vernieri F, Ursini F, Mundi C, Frisoni GB, Rossini PM (2014) Cortical sources of resting state electroencephalographic alpha rhythms deteriorate across time in subjects with amnesic mild cognitive impairment. Neurobiol Aging 35:130–142
12. Barter PJ et al (2006) Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel. J Intern Med 259:247–258
13. Becker JA, Hedden T, Carmasin J, Maye J, Rentz DM, Putcha D, Fischl B, Greve DN, Marshall GA, Salloway S, Marks D, Buckner RL, Sperling RA, Johnson KA (2011) Amyloid-β associated cortical thinning in clinically normal elderly. Ann Neurol 69:1032–1042
14. Benito-Leon J, Louis ED, Vega S, Bermejo-Pareja F (2010) Statins and cognitive functioning in the elderly: a population-based study. J Alzheimers Dis 21:95–102
15. Bishop NA, Lu T, Yankner BA (2010) Neural mechanisms of ageing and cognitive decline. Nature 464:529–535
16. Blasko I, Jellinger K, Kemmler G, Krampla W, Jungwirth S, Wichart I, Tragl KH, Fischer P (2008) Conversion from cognitive health to mild cognitive impairment and Alzheimer’s disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine. Neurobiol Aging 29:1–11
17. Blesa R, Pujol M, Aguilar M, Santacruz P, Bertran-Serra I, Hernández G, Sol JM, Peña-Casanova J, NORMACODEM Group (2001) Clinical validity of the ‘mini-mental state’ for Spanish speaking communities. Neuropsychologia 39:1150–1157
18. Bodovitz S, Klein WL (1996) Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein. J Biol Chem 271:4436–4440
19. Braak H, Braak E (1991) Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1:213–216
20. Brier MR, Thomas JB, Snyder AZ, Benzinger TL, Zhang D, Raichle ME, Holtzman DM, Morris JC, Ances BM (2012) Loss of intranetwork and internetwork resting state functional connections with Alzheimer’s disease progression. J Neurosci 32:8890–8899
21. Burgess BL, McIsaac SA, Naus KE, Chan JY, Tansley GH, Yang J, Miao F, Ross CJ, van Eck M, Hayden MR, van Nostrand W, St George-Hyslop P, Westaway D, Wellington CL (2006) Elevated plasma triglyceride levels precede amyloid deposition in Alzheimer’s disease mouse models with abundant A beta in plasma. Neurobiol Dis 24:114–127
22. Cantero JL, Atienza M, Gomez-Herrero G, Cruz-Vadell A, Gil-Neciga E, Rodriguez-Romero R, Garcia-Solis D (2009a) Functional integrity of thalamocortical circuits differentiates normal aging from mild cognitive impairment. Hum Brain Mapp 30:3944–3957
23. Cantero JL, Atienza M, Cruz-Vadell A, Suarez-Gonzalez A, Gil-Neciga E (2009b) Increased synchronization and decreased neural complexity underlie thalamocortical oscillatory dynamics in mild cognitive impairment. Neuroimage 46:938–948
24. Cao L, Schrank BR, Rodriguez S, Benz EG, Moulia TW, Rickenbacher GT, Gomez AC, Levites Y, Edwards SR, Golde TE, Hyman BT, Barnea G, Albers MW (2012) Aβ alters the connectivity of olfactory neurons in the absence of amyloid plaques in vivo. Nat Commun 3:1009
25. Caramelli P, Nitrini R, Maranhão R, Lourenço AC, Damasceno MC, Vinagre C, Caramelli B (1999) Increased apolipoprotein B serum concentration in Alzheimer’s disease. Acta Neurol Scand 100:61–63
26. Cheng N, Bai L, Steuer E, Belluscio L (2013) Olfactory functions scale with circuit restoration in a rapidly reversible Alzheimer’s disease model. J Neurosci 33:12208–12217
27. De Jong LW, Van der Hiele K, Veer IM, Houwing JJ, Westendorp RG, Bollen EL, De Bruin PW, Middelkoop HA, Van Buchem MA, Van der Grond J (2008) Strongly reduced volumes of putamen and thalamus in Alzheimer’s disease: an MRI study. Brain 131:3277–3285
28. De Munck JC, Gonçalves SI, Huijboom L, Kuijer JP, Pouwels PJ, Heethaar RM, Lopes da Silva FH (2007) The hemodynamic response of the alpha rhythm: an EEG/fMRI study. Neuroimage 35:1142–1151
29. DeKosky ST, Scheff SW (1990) Synapse loss in frontal cortex biopsies in Alzheimer’s disease: correlation with cognitive severity. Ann Neurol 27:457–464
30. Di Paolo G, Kim TW (2011) Linking lipids to Alzheimer’s disease: cholesterol and beyond. Nat Rev Neurosci 12:284–296
31. Driscoll I, Troncoso JC, Rudow G, Sojkova J, Pletnikova O, Zhou Y, Kraut MA, Ferrucci L, Mathis CA, Klunk WE, O’Brien RJ, Davatzikos C, Wong DF, Resnick SM (2012) Correspondence between in vivo (11)C-PiB-PET amyloid imaging and postmortem, region-matched assessment of plaques. Acta Neuropathol 124:823–831
32. Drzezga A, Becker JA, Van Dijk KR, Sreenivasan A, Talukdar T, Sullivan C, Schultz AP, Sepulcre J, Putcha D, Greve D, Johnson KA, Sperling RA (2011) Neuronal dysfunction and disconnection of cortical hubs in non-demented subjects with elevated amyloid burden. Brain 134:1635–1646
33. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA (1987) MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. Am J Roentgenol 149:351–356
34. Feige B, Scheffler K, Esposito F, Di Salle F, Hennig J, Seifritz E (2005) Cortical and subcortical correlates of electroencephalographic alpha rhythm modulation. J Neurophysiol 93:2864–2872
35. Fischl B, Sereno MI, Dale AM (1999a) Cortical surface-based analysis. II: inflation, flattening, and a surface-based coordinate system. Neuroimage 9:195–207
36. Fischl B, Sereno MI, Tootell RB, Dale AM (1999b) High-resolution intersubject averaging and a coordinate system for the cortical surface. Hum Brain Mapp 8:272–284
37. Ghribi O (2008) Potential mechanisms linking cholesterol to Alzheimer’s disease-like pathology in rabbit brain, hippocampal organotypic slices, and skeletal muscle. J Alzheimers Dis 15:673–684
38. Giovacchini G, Lerner A, Toczek MT, Fraser C, Ma K, DeMar JC, Herscovitch P, Eckelman WC, Rapoport SI, Carson RE (2004) Brain incorporation of 11C-arachidonic acid, blood volume, and blood flow in healthy aging: a study with partial-volume correction. J Nucl Med 45:1471–1479
39. Goldman RI, Stern JM, Engel J Jr, Cohen MS (2002) Simultaneous EEG and fMRI of the alpha rhythm. Neuroreport 13:2487–2492
40. Graff-Radford NR, Crook JE, Lucas J, Boeve BF, Knopman DS, Ivnik RJ, Smith GE, Younkin LH, Petersen RC, Younkin SG (2007) Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease. Arch Neurol 64:354–362
41. Greicius MD, Srivastava G, Reiss AL, Menon V (2004) Default-mode network activity distinguishes Alzheimer’s disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci USA 101:4637–4642
42. Grimm MO, Grimm HS, Tomic I, Beyreuther K, Hartmann T, Bergmann C (2008) Independent inhibition of Alzheimer disease beta- and gamma-secretase cleavage by lowered cholesterol levels. J Biol Chem 283:11302–11311
43. Grösgen S, Grimm MO, Friess P, Hartmann T (2010) Role of amyloid beta in lipid homeostasis. Biochim Biophys Acta 1801:966–974
44. Hof PR, Morrison JH (2004) The aging brain: morphomolecular senescence of cortical circuits. Trends Neurosci 27:607–613
45. Hof PR, Cox K, Morrison JH (1990) Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer’s disease: I. SUPERIOR frontal and inferior temporal cortex. J Comp Neurol 301:44–54
46. Hsia AY, Masliah E, McConlogue L, Yu GQ, Tatsuno G, Hu K, Kholodenko D, Malenka RC, Nicoll RA, Mucke L (1999) Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models. Proc Natl Acad Sci USA 96:3228–32233
47. Hughes SW, Lörincz M, Cope DW, Blethyn KL, Kekesi KA, Parri HR, Juhasz G, Crunelli V (2004) Synchronized oscillations at alpha and theta frequencies in the lateral geniculate nucleus. Neuron 42:253–268
48. Humpel C (2011) Identifying and validating biomarkers for Alzheimer’s disease. Trends Biotechnol 29:26–32
49. Iacono D, Markesbery WR, Gross M, Pletnikova O, Rudow G, Zandi P, Troncoso JC (2009) The Nun study: clinically silent AD, neuronal hypertrophy, and linguistic skills in early life. Neurology 73:665–673
50. Karas GB, Scheltens P, Rombouts SA, Visser PJ, van Schijndel RA, Fox NC, Barkhof F (2004) Global and local gray matter loss in mild cognitive impairment and Alzheimer’s disease. Neuroimage 23:708–716
51. Katzman R, Terry R, DeTeresa R, Brown T, Davies P, Fuld P, Renbing X, Peck A (1988) Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol 23:138–144
52. Koyama A, Okereke OI, Yang T, Blacker D, Selkoe DJ, Grodstein F (2012) Plasma amyloid-β as a predictor of dementia and cognitive decline: a systematic review and meta-analysis. Arch Neurol 69:824–831
53. Lachaux JP, Rodriguez E, Martinerie J, Varela FJ (1999) Measuring phase synchrony in brain signals. Hum Brain Mapp 8:194–208
54. Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, Viola KL, Klein WL (2007) Aβ oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer’s disease. J Neurosci 27:796–807
55. Lamarche B, Moorjani S, Lupien PJ, Cantin B, Bernard PM, Dagenais GR, Després JP (1996) Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec cardiovascular study. Circulation 94:273–278
56. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL (1998) Diffusible, nonfibrillar ligands derived from Abeta1–42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95:6448–6453
57. Leritz EC, Salat DH, Williams VJ, Schnyer DM, Rudolph JL, Lipsitz L, Fischl B, McGlinchey RE, Milberg WP (2011) Thickness of the human cerebral cortex is associated with metrics of cerebrovascular health in a normative sample of community dwelling older adults. Neuroimage 54:2659–26571
58. Lesné S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH (2006) A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440:352–357
59. Lopes da Silva F (1991) Neural mechanisms underlying brain waves: from neural membranes to networks. Electroencephalogr Clin Neurophysiol 79:81–93
60. Lopes da Silva F, Van Rotterdam A (1993) Biophysical aspects of EEG and magnetoencephalogram generation. In: Niedermeyer E, Lopes da Silva FH (eds) Electroencephalography. Basic principles, clinical applications and related fields. Williams and Wilkins, Baltimore, pp 78–91
61. Lopes da Silva FH, van Lierop TH, Schrijer CF, van Leeuwen WS (1973) Organization of thalamic and cortical alpha rhythms: spectra and coherences. Electroencephalogr Clin Neurophysiol 35:627–639
62. Maris E (2004) Randomization tests for ERP topographies and whole spatiotemporal data matrices. Psychophysiology 41:142–151
63. Martins IJ, Berger T, Sharman MJ, Verdile G, Fuller SJ, Martins RN (2009) Cholesterol metabolism and transport in the pathogenesis of Alzheimer’s disease. J Neurochem 111:1275–1308
64. Masliah E, Terry R, Buzsaki G (1989) Thalamic nuclei in Alzheimer disease: evidence against the cholinergic hypothesis of plaque formation. Brain Res 493:241–246
65. Masliah E, Mallory M, Hansen L, DeTeresa R, Terry RD (1993) Quantitative synaptic alterations in the human neocortex during normal aging. Neurology 43:192–197
66. Masliah E, Mallory M, Alford M, DeTeresa R, Hansen LA, McKeel DW Jr, Morris JC (2001) Altered expression of synaptic proteins occurs early during progression of Alzheimer’s disease. Neurology 56:127–129
67. Michels L, Moazami-Goudarzi M, Jeanmonod D, Sarnthein J (2008) EEG alpha distinguishes between cuneal and precuneal activation in working memory. Neuroimage 40:1296–1310
68. Miller S, Dykes D, Polesky H (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
69. Motta M, Bennati E, Cardillo E, Ferlito L, Passamonte M, Malaguarnera M (2009) The significance of apolipoprotein-B (Apo-B) in the elderly as a predictive factor of cardio-cerebrovascular complications. Arch Gerontol Geriatr 49:162–164
70. Mucke L, Masliah E, Yu GQ, Mallory M, Rockenstein EM, Tatsuno G, Hu K, Kholodenko D, Johnson-Wood K, McConlogue L (2000) High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci 20:4050–4058
71. Nickl-Jockschat T, Kleiman A, Schulz JB, Schneider F, Laird AR, Fox PT, Eickhoff SB, Reetz K (2012) Neuroanatomic changes and their association with cognitive decline in mild cognitive impairment: a meta-analysis. Brain Struct Funct 217:115–125
72. Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, Yoo J, Ho KO, Yu GQ, Kreitzer A, Finkbeiner S, Noebels JL, Mucke L (2007) Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer’s disease. Neuron 55:697–711
73. Panza F, D’Introno A, Colacicco AM, Capurso C, Pichichero G, Capurso SA, Capurso A, Solfrizzi V (2006) Lipid metabolism in cognitive decline and dementia. Brain Res Rev 51:275–292
74. Pappolla MA, Bryant-Thomas TK, Herbert D, Pacheco J, Fabra Garcia M, Manjon M, Girones X, Henry TL, Matsubara E, Zambon D, Wolozin B, Sano M, Cruz-Sanchez FF, Thal LJ, Petanceska SS, Refolo LM (2003) Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology. Neurology 61:199–205
75. Pereda E, Quian Quiroga R, Bhattacharya J (2005) Nonlinear multivariate analysis of neurophysiological signals. Prog Neurobiol 77:1–37
76. Perrotin A, Mormino EC, Madison CM, Hayenga AO, Jagust WJ (2012) Subjective cognition and amyloid deposition imaging: a Pittsburgh Compound B positron emission tomography study in normal elderly individuals. Arch Neurol 69:223–229
77. Pesini P, Pérez-Grijalba V, Monleón I, Boada M, Tárraga L, Martínez-Lage P, San-José I, Sarasa M (2012) Reliable measurements of the β-amyloid pool in blood could help in the early diagnosis of AD. Int J Alzheimers Dis 2012:604141
78. Peters R, Beckett N (2009) Hypertension, dementia, and antihypertensive treatment: implications for the very elderly. Curr Hypertens Rep 11:277–282
79. Petersen PR, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment. Clinical characterization and outcome. Arch Neurol 56:303–308
80. Price JL, Morris JC (1999) Tangles and plaques in nondemented aging and “preclinical” Alzheimer’s disease. Ann Neurol 45:358–368
81. Price JL, Davis PB, Morris JC, White DL (1991) The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer’s disease. Neurobiol Aging 12:295–312
82. Refolo LM, Malester B, LaFrancois J, Bryant-Thomas T, Wang R, Tint GS, Sambamurti K, Duff K, Pappolla MA (2000) Hypercholesterolemia accelerates the Alzheimer’s amyloid pathology in a transgenic mouse model. Neurobiol Dis 7:321–331
83. Richardson K, Schoen M, French B, Umscheid CA, Mitchell MD, Arnold SE, Heidenreich PA, Rader DJ, deGoma EM (2013) Statins and cognitive function: a systematic review. Ann Intern Med 159:688–697
84. Rogers J, Morrison JH (1985) Quantitative morphology and regional and laminar distribution of senile plaques in Alzheimer’s disease. J Neurosci 5:2801–2808
85. Roher AE, Kuo YM, Kokjohn KM, Emmerling MR, Gracon S (1999) Amyloid and lipids in the pathology of Alzheimer disease. Amyloid 6:136–145
86. Rowe CC, Ng S, Ackermann U, Gong SJ, Pike K, Savage G, Cowie TF, Dickinson KL, Maruff P, Darby D, Smith C, Woodward M, Merory J, Tochon-Danguy H, O’Keefe G, Klunk WE, Mathis CA, Price JC, Masters CL, Villemagne VL (2007) Imaging beta-amyloid burden in aging and dementia. Neurology 68:1718–1725
87. Rudelli RD, Ambler MW, Wisniewski HM (1984) Morphology and distribution of Alzheimer neuritic (senile) and amyloid plaques in striatum and diencephalon. Acta Neuropathol 64:273–281
88. Scheff SW, Price DA, Schmitt FA, Mufson EJ (2006) Hippocampal synaptic loss in early Alzheimer’s disease and mild cognitive impairment. Neurobiol Aging 27:1372–1384
89. Schiff SJ (2005) Dangerous phase. Neuroinformatics 3:315–318
90. Schreckenberger M, Lange-Asschenfeldt C, Lochmann M, Mann K, Siessmeier T, Buchholz HG, Bartenstein P, Gründer G (2004) The thalamus as the generator and modulator of EEG alpha rhythm: a combined PET/EEG study with lorazepam challenge in humans. Neuroimage 22:637–644
91. Shobab LA, Hsiung GY, Feldman HH (2005) Cholesterol in Alzheimer’s disease. Lancet Neurol 4:841–852
92. Silva LR, Amitai Y, Connors BW (1991) Intrinsic oscillations of neocortex generated by layer 5 pyramidal neurons. Science 251:432–435
93. Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, Simons K (1998) Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Natl Acad Sci USA 95:6460–6464
94. Snowdon DA, Nun Study (2003) Healthy aging and dementia: findings from the Nun Study. Ann Intern Med 139:450–454
95. Sobów T, Flirski M, Kłoszewska I, Liberski PP (2005) Plasma levels of alpha beta peptides are altered in amnestic mild cognitive impairment but not in sporadic Alzheimer’s disease. Acta Neurobiol Exp (Wars) 65:117–124
96. Stam CJ, Jones BF, Manshanden I, van Cappellen van Walsum AM, Montez T, Verbunt JPA, de Munck JC, van Dijk BW, Berendse HW, Scheltens P (2006) Magnetoencephalographic evaluation of resting-state functional connectivity in Alzheimer’s disease. Neuroimage 32:1335–1344
97. Stam CJ, Nolte G, Daffertshofer A (2007) Phase lag index: assessment of functional connectivity from multi channel EEG and MEG with diminished bias from common sources. Hum Brain Mapp 28:1178–1193
98. Storace D, Cammarata S, Borghi R, Sanguineti R, Giliberto L, Piccini A, Pollero V, Novello C, Caltagirone C, Smith MA, Bossù P, Perry G, Odetti P, Tabaton M (2010) Elevation of beta-amyloid 1-42 autoantibodies in the blood of amnestic patients with mild cognitive impairment. Arch Neurol 67:867–872
99. Sun X, Bhadelia R, Liebson E, Bergethon P, Folstein M, Zhu JJ, Mwamburi DM, Patz S, Qiu WQ (2011) The relationship between plasma amyloid-β peptides and the medial temporal lobe in the homebound elderly. Int J Geriatr Psychiatry 26:593–601
100. Swiger KJ, Manalac RJ, Blumenthal RS, Blaha MJ, Martin SS (2013) Statins and cognition: a systematic review and meta-analysis of short- and long-term cognitive effects. Mayo Clin Proc 88:1213–1221
101. Tabet N, Quinn R, Klugman A (2009) Prevalence and cognitive impact of cerebrovascular findings in Alzheimer’s disease: a retrospective, naturalistic study. Int J Clin Pract 63:338–345
102. Terry RD, Peck A, DeTeresa R, Schechter R, Horoupian DS (1981) Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann Neurol 10:184–192
103. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572–580
104. Tomlinson BE, Blessed G, Roth M (1968) Observations on the brains of non-demented old people. J Neurol Sci 7:331–356
105. Toth M, Kiss A, Kosztolanyi P, Kondakor I (2007) Diurnal alterations of brain electrical activity in healthy adults: a LORETA study. Brain Topogr 20:63–76
106. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416:535–539
107. Wang Z, Jia X, Liang P, Qi Z, Yang Y, Zhou W, Li K (2012) Changes in thalamus connectivity in mild cognitive impairment: evidence from resting state fMRI. Eur J Radiol 81:277–285
108. Williams VJ, Leritz EC, Shepel J, McGlinchey RE, Milberg WP, Rudolph JL, Lipsitz LA, Salat DH (2013) Interindividual variation in serum cholesterol is associated with regional white matter tissue integrity in older adults. Hum Brain Mapp 34:1826–1841
109. Wirth M, Oh H, Mormino EC, Markley C, Landau SM, Jagust WJ (2013) The effect of amyloid β on cognitive decline is modulated by neural integrity in cognitively normal elderly. Alzheimers Dement 9:687–698
110. Wood WG, Schroeder F, Avdulov NA, Chochina SV, Igbavboa U (1999) Recent advances in brain cholesterol dynamics: transport, domains, and Alzheimer’s disease. Lipids 34:225–234
111. Xiong H, Callaghan D, Jones A, Walker DG, Lue LF, Beach TG, Sue LI, Woulfe J, Xu H, Stanimirovic DB, Zhang W (2008) Cholesterol retention in Alzheimer’s brain is responsible for high beta- and gamma-secretase activities and Abeta production. Neurobiol Dis 29:422–437
112. Yesavage JA, BrinK TL, Rose TL, Lum O (1983) Development and validation of a geriatric depression scale: a preliminary report. J Psychiat Res 17:37–49
113. Yotter RA, Doshi J, Clark V, Sojkova J, Zhou Y, Wong DF, Ferrucci L, Resnick SM, Davatzikos C (2013) Memory decline shows stronger associations with estimated spatial patterns of amyloid deposition progression than total amyloid burden. Neurobiol Aging 34:2835–2842
114. Zhou B, Liu Y, Zhang Z, An N, Yao H, Wang P, Wang L, Zhang X, Jiang T (2013) Impaired functional connectivity of the thalamus in Alzheimer’s disease and mild cognitive impairment: a resting-state FMRI study. Curr Alzheimer Res 10:754–766